Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2024Nephrology Dialysis TransplantationOpen Access

#1194 Roxadustat in ESA converted patients with anemia of chronic kidney disease on dialysis: a secondary analysis of ROXSTAR Registry

View Full Paper
Ask AI
Bookmark
Share

Authors

JYJurong YangJCJianghua ChenYWYiqing Wu

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yang et al. (2024) studied this question.

synapsesocial.com/papers/68e6c82cb6db64358764655dhttps://doi.org/10.1093/ndt/gfae069.1474
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1#1168 Responsiveness to roxadustat in chronic kidney disease associated anemia patients by baseline hemoglobin: a secondary analysis of ROXSTAR Registry2024 · 1 citations
  2. 2Roxadustat for Erythropoiesis-Stimulating Agent Hyporesponsive Anemia in Hemodialysis: Multicenter Retrospective Analysis2026 · 1 citations
  3. 3Roxadustat Versus <scp>ESA</scp> Therapy for Sustained Hemoglobin Response in <scp>ESA</scp> ‐Hyporesponsive Hemodialysis Patients2026
  4. 4#2352 Short-term effect of roxadustat combined with ESA treatment for anemia in patients undergoing hemodialysis with ESA hyporesponsiveness2024
  5. 5P42 | Efficacy and safety of roxadustat in patients with non-dialysis-dependent chronic kidney disease with or without inflammation: pooled analysis of four phase 3 studies2025